Company intelligence / Profile preview

JUXIAN Pharmaceutical

China

Ownership: Private
Development stage: Other

Overview

JUXIAN Pharmaceutical, established in 2009, engages in scientific research, production, and sales within the pharmaceutical sector. The company has a complete production system and focuses on innovative drug development. In November 2024, it entered a strategic partnership with Evergreen Therapeutics to leverage AI for accelerating new drug R&D. This collaboration aims to enhance precision and efficiency in developing innovative therapies.

Modalities: Small molecule
Industry: Biotech

Partnerships

Evergreen Therapeutics (strategic R&D/AI collaboration)

Beyond the preview

Go deeper on JUXIAN Pharmaceutical.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on JUXIAN Pharmaceutical.

Explore the full profile